| The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours P Goldstraw, J Crowley, K Chansky, DJ Giroux, PA Groome, R Rami-Porta, ... Journal of thoracic oncology 2 (8), 706-714, 2007 | 4587* | 2007 |
| Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ... Nature 545 (7655), 446-451, 2017 | 1486 | 2017 |
| Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up PE Postmus, KM Kerr, M Oudkerk, S Senan, DA Waller, J Vansteenkiste, ... Annals of oncology 28, iv1-iv21, 2017 | 1477 | 2017 |
| Prophylactic cranial irradiation in extensive small-cell lung cancer B Slotman, C Faivre-Finn, G Kramer, E Rankin, M Snee, M Hatton, ... New England Journal of Medicine 357 (7), 664-672, 2007 | 1254 | 2007 |
| Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial H Van Tinteren, OS Hoekstra, EF Smit, JHAM Van Den Bergh, ... The Lancet 359 (9315), 1388-1392, 2002 | 998 | 2002 |
| Allele-specific HLA loss and immune escape in lung cancer evolution N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ... Cell 171 (6), 1259-1271. e11, 2017 | 995 | 2017 |
| Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension SA van Wolferen, JT Marcus, A Boonstra, KMJ Marques, JGF Bronzwaer, ... European heart journal 28 (10), 1250-1257, 2007 | 861 | 2007 |
| Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. D Curran, T Sahmoud, P Therasse, J van Meerbeeck, PE Postmus, ... Journal of Clinical Oncology 16 (1), 145-152, 1998 | 608 | 1998 |
| Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM … P Goldstraw, J Crowley, K Chansky, DJ Giroux, PA Groome, R Rami-Porta, ... J Thorac Oncol 2 (8), 706-714, 2007 | 603 | 2007 |
| Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European … A Ardizzoni, H Hansen, P Dombernowsky, T Gamucci, S Kaplan, ... Journal of clinical oncology 15 (5), 2090-2096, 1997 | 563 | 1997 |
| The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming … FA Shepherd, J Crowley, P Van Houtte, PE Postmus, D Carney, ... Journal of thoracic oncology 2 (12), 1067-1077, 2007 | 548 | 2007 |
| The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the … E Vallieres, FA Shepherd, J Crowley, P Van Houtte, PE Postmus, ... Journal of thoracic oncology 4 (9), 1049-1059, 2009 | 480 | 2009 |
| Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer K Kok, J Osinga, B Carritt, MB Davis, AH van der Hout, AY van der Veen, ... Nature 330 (6148), 578-581, 1987 | 472 | 1987 |
| Fc effector function contributes to the activity of human anti-CTLA-4 antibodies FA Vargas, AJS Furness, K Litchfield, K Joshi, R Rosenthal, E Ghorani, ... Cancer cell 33 (4), 649-663. e4, 2018 | 463 | 2018 |
| Current aspects of spontaneous pneumothorax FM Schramel, PE Postmus, RG Vanderschueren European Respiratory Journal 10 (6), 1372-1379, 1997 | 453 | 1997 |
| Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension CTJ Gan, JW Lankhaar, N Westerhof, JT Marcus, A Becker, JWR Twisk, ... Chest 132 (6), 1906-1912, 2007 | 421 | 2007 |
| Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ... Immunity 46 (4), 577-586, 2017 | 369 | 2017 |
| Right ventricular diastolic impairment in patients with pulmonary arterial hypertension S Rain, ML Handoko, P Trip, CTJ Gan, N Westerhof, GJ Stienen, ... Circulation 128 (18), 2016-2025, 2013 | 363 | 2013 |
| Quantification of right ventricular afterload in patients with and without pulmonary hypertension JW Lankhaar, N Westerhof, TJC Faes, KMJ Marques, JT Marcus, ... American Journal of Physiology-Heart and Circulatory Physiology 291 (4 …, 2006 | 356 | 2006 |
| Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs AAM Van der Veldt, M Lubberink, I Bahce, M Walraven, MP de Boer, ... Cancer cell 21 (1), 82-91, 2012 | 352 | 2012 |
